Marc Diederich

30.0k total citations · 1 hit paper
278 papers, 13.0k citations indexed

About

Marc Diederich is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Marc Diederich has authored 278 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Molecular Biology, 40 papers in Organic Chemistry and 38 papers in Pharmacology. Recurrent topics in Marc Diederich's work include Histone Deacetylase Inhibitors Research (37 papers), Genomics, phytochemicals, and oxidative stress (32 papers) and Epigenetics and DNA Methylation (25 papers). Marc Diederich is often cited by papers focused on Histone Deacetylase Inhibitors Research (37 papers), Genomics, phytochemicals, and oxidative stress (32 papers) and Epigenetics and DNA Methylation (25 papers). Marc Diederich collaborates with scholars based in Luxembourg, South Korea and France. Marc Diederich's co-authors include Mario Dicato, Michaël Schnekenburger, Claudia Cerella, Franck Morceau, Lina Ghibelli, Flavia Radogna, Marc Schumacher, Sébastien Chateauvieux, Barbora Orlikova and Sylvie Delhalle and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Marc Diederich

272 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemopreventive and therapeutic effects of curcumin

2004 729 citations Romain Blasius, Michaël Schnekenburger et al. Cancer Letters profile →

Peers

Countries citing papers authored by Marc Diederich

Since Specialization

Citations

This map shows the geographic impact of Marc Diederich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Diederich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Diederich more than expected).

Fields of papers citing papers by Marc Diederich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Diederich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Diederich. The network helps show where Marc Diederich may publish in the future.

Co-authorship network of co-authors of Marc Diederich

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Diederich. A scholar is included among the top collaborators of Marc Diederich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Diederich. Marc Diederich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia 2025 ·Cancer Letters ·(unknown), (unknown), Yejin Lee, (unknown), (unknown), (unknown), Anne Lorant, Michaël Schnekenburger, Davide Brusa, (unknown), Sérgio Valente, Antonello Mai, Sarah Skuli, Martin Carroll, Sebastian Böttcher, Jean‐Emmanuel Sarry, Claudia Cerella, Franck Morceau, Marc Diederich	0
2	New rhodol-sulforaphane conjugates as innovative isothiocyanate-based cytotoxic agents for cancer cells 2024 ·European Journal of Medicinal Chemistry ·Andrea Milelli, Elena Catanzaro, Giulia Greco, Cinzia Calcabrini, Eleonora Turrini, Francesca Maffei, Sabrina Burattini, (unknown), Claudia Sissi, Michaël Schnekenburger, Marc Diederich, Piero Sestili, Carmela Fimognari	1
3	Bioactive Bromotyrosine Derivatives from the Pacific Marine Sponge Suberea clavata (Pulitzer-Finali, 1982) 2021 ·Marine Drugs ·Céline Moriou, Damien Lacroix, Sylvain Petek, Amr El‐Demerdash, Rozenn Trépos, (unknown), Cristina Florean, Marc Diederich, Claire Hellio, Cécile Debitus, (unknown)	21
4	Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues 2021 ·European Journal of Medicinal Chemistry ·(unknown), Abdallah Hamzé, Jérôme Bignon, (unknown), Alain Deroussent, Laura Gallego‐Yerga, Rafael Peláez, (unknown), Marc Diederich, Mouâd Alami, Olivier Provot	28
5	Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary 2021 ·International Journal of Molecular Sciences ·(unknown), Giulia Pucci, Francesco Marchetti, Marc Diederich, Stefania Gonfloni	10
6	Personalized nutrition in ageing society: redox control of major-age related diseases through the NutRedOx Network (COST Action CA16112) 2019 ·Free Radical Research ·Josep A. Tur, Claus Jacob, Patrick Chaimbault, Mohammad Tadayyon, Elke Richling, Nina Hermans, Cláudia Nunes dos Santos, Marc Diederich, Linda Giblin, (unknown), Caroline Gaucher, Pierre Andreoletti, Ana S. Fernandes, Michael J. Davies, Agnieszka Bartoszek, Mustapha Cherkaoui‐Malki	4
7	Natural modulators of the hallmarks of immunogenic cell death 2019 ·Biochemical Pharmacology ·Flavia Radogna, Mario Dicato, Marc Diederich	37
8	Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A 2015 ·Anti-Cancer Agents in Medicinal Chemistry ·Cindy Grandjenette, Michaël Schnekenburger, Franck Morceau, (unknown), (unknown), Oliver Werz, Mario Dicato, Marc Diederich	12
9	Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines 2014 ·Bioorganic & Medicinal Chemistry Letters ·Carole Seidel, Michaël Schnekenburger, Clemens Zwergel, François Gaascht, Antonello Mai, Mario Dicato, Gilbert Kirsch, Sérgio Valente, Marc Diederich	40
10	Polyphenol tri-vanillic ester 13c inhibits P-JAK2V617F and Bcr–Abl oncokinase expression in correlation with STAT3/STAT5 inactivation and apoptosis induction in human leukemia cells 2013 ·Cancer Letters ·(unknown), Franck Morceau, Anthoula Gaigneaux, (unknown), Sébastien Chateauvieux, Cindy Grandjenette, Mario Dicato, Marc Diederich	7
11	Antioxidant and anti-proliferative properties of lycopene 2011 ·Free Radical Research ·Mareike Kelkel, Marc Schumacher, Mario Dicato, Marc Diederich	161
12	Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Sébastien Taurin, Rhonda J. Rosengren, Marc Schumacher, Marc Diederich, Tiffany J. Somers‐Edgar, Lesley Larsen	93
13	Sp proteins play a critical role in histone deacetylase inhibitor‐mediated derepression of CYP46A1 gene transcription 2010 ·Journal of Neurochemistry ·Maria João Nunes, Inês Milagre, Michaël Schnekenburger, Maria João Gama, Marc Diederich, Elsa Rodrigues	36
14	Natural compounds and their role in apoptotic cell signaling pathways 2009 ·Marc Diederich	14
15	Marine cytotoxins: callers for the various dances of death 2009 ·Florence Folmer, Marcel Jaspars, Mario Dicato, Marc Diederich	15
16	Linking anemia to inflammation and cancer: The crucial role of TNFα 2009 ·Biochemical Pharmacology ·(unknown), Franck Morceau, (unknown), Mario Dicato, Marc Diederich	50
17	Radicicol-mediated inhibition of Bcr-Abl in K562 cells induced p38-MAPK dependent erythroid differentiation and PU.1 down-regulation. 2008 ·PubMed ·Franck Morceau, (unknown), Mario Dicato, Marc Diederich	12
18	Effect of Curcumin Treatment on Protein Phosphorylation in K562 Cells 2007 ·Annals of the New York Academy of Sciences ·Romain Blasius, Mario Dicato, Marc Diederich	3
19	Signal transduction pathways, chromatin structure, and gene expression mechanisms as therapeutic targets 2004 ·New York Academy of Sciences eBooks ·Marc Diederich	4
20	GATA‐1: Friends, Brothers, and Coworkers 2004 ·Annals of the New York Academy of Sciences ·Franck Morceau, Michaël Schnekenburger, Mario Dicato, Marc Diederich	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact